Kristie L. Kahl is vice president of content at MJH Life Sciences, overseeing CURE®, CancerNetwork®, the journal ONCOLOGY, Targeted Oncology, and Urology Times®. She has been with the company since November 2017.
She is a graduate of Rider University, where she acquired a Bachelors of Art in journalism, as well as a graduate of Temple University, where she received her Masters of Science in Sports Management.
Follow Kristie on Twitter at @KristieLKahl, or email her at kkahl@mjhlifesciences.com.
Breaking Barriers: An Egyptian Immigrant's Journey with ALL
February 13th 2020In this episode of the “CURE Talks Cancer” podcast, we spoke with Bishoy Tadros, who went on to break barriers after he was diagnosed with acute lymphoblastic leukemia at the age of 3 and immigrated to the United States from Egypt to receive treatment.
Read More
Eradicating Infection to Reduce Gastric Cancer Risk
February 7th 2020Study findings showed that eradicating Helicobacter pylori infection reduced the risk of developing gastric cancer by 73% in those with a first-degree relative with the disease, compared with individuals in whom infection was persistent.
Read More
Seven Times Down, Eight Times Up
February 6th 2020In this episode of the “CURE Talks Cancer” podcast, we spoke with a survivor on two very rare types of cancer, called pheochromocytoma and paraganglioma, and why more research behind these two diseases can help put together the pieces of the cancer puzzle.
Read More
High BMI May Be Associated With Improved Survival Following Tecentriq Therapy in NSCLC
January 28th 2020In a first-of-its-kind analysis, researchers found that high body mass index may be associated with improved survival in Tecentriq-treated patients with advanced non–small cell lung cancer.
Read More
Equal Access Health Care May Improve Survival Outcomes Among Men with Prostate Cancer
January 28th 2020A study of the Veterans Affairs health system found that, despite trends suggesting otherwise, African American men with prostate cancer had similar survival outcomes, compared with non-Hispanic White men.
Read More
Discontinuation of Jakafi May Result in Poorer Survival in Myelofibrosis Treatment
January 25th 2020Survival among patients with myelofibrosis who discontinued treatment with Jakafi appeared to have poorer survival, which was most prominent in those who stopped during the blast phase of treatment.
Read More
Immune-Related Side Effects After Keytruda Treatment Could Indicate Improved Responses
January 22nd 2020Patients with high-risk stage 3 melanoma who experienced an immune-related side effect after treatment with adjuvant Keytruda had reduced risk for disease recurrence, compared with those on the placebo arm.
Read More
Price Transparency May Not Aid Patients in Preparing for Financial Toxicity
January 17th 2020How providers communicate medical bills to payers and patients, mandated by the US Centers for Medicare & Medicaid Services, still did not help patients and health care professionals in understanding differences in cost.
Read More
Psychosocial Intervention for Caregivers May Improve Quality of Life
January 16th 2020A brief, multimodal psychosocial intervention for caregivers of patients undergoing hematopoietic stem cell transplantation could improve their quality of life, caregiving burden and anxiety and depression symptoms.
Read More
Information at Your Fingertips
January 16th 2020In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with the associate director of the Information Resource Center at the Leukemia and Lymphoma Society on support groups and other recourses available for those affected by blood cancer.
Read More
Use of Antioxidants During Chemotherapy May Increase Risk for Breast Cancer Recurrence
January 16th 2020Researchers from Roswell Park Comprehensive Cancer Center found that the use of supplements, besides a multivitamin, while patients were being treated with chemotherapy increased their risk for breast cancer recurrence or death.
Read More